Sigrid Vorobjov

624 total citations
27 papers, 261 citations indexed

About

Sigrid Vorobjov is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sigrid Vorobjov has authored 27 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sigrid Vorobjov's work include HIV, Drug Use, Sexual Risk (11 papers), HIV/AIDS Research and Interventions (8 papers) and Opioid Use Disorder Treatment (6 papers). Sigrid Vorobjov is often cited by papers focused on HIV, Drug Use, Sexual Risk (11 papers), HIV/AIDS Research and Interventions (8 papers) and Opioid Use Disorder Treatment (6 papers). Sigrid Vorobjov collaborates with scholars based in Estonia, United States and Czechia. Sigrid Vorobjov's co-authors include Anneli Uusküla, Don C. Des Jarlais, Ave Talu, Kristi Rüütel, Aare Märtson, Katri Abel‐Ollo, Mait Raag, Robert Heimer, Olga Levina and Elina Hemminki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Environmental Research and Public Health.

In The Last Decade

Sigrid Vorobjov

25 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sigrid Vorobjov Estonia 11 117 78 61 51 29 27 261
Dahn Jeong Canada 12 172 1.5× 91 1.2× 43 0.7× 21 0.4× 10 0.3× 41 385
Alka Ganesh India 10 112 1.0× 76 1.0× 73 1.2× 58 1.1× 15 0.5× 19 319
Tadao Ooka Japan 11 66 0.6× 52 0.7× 49 0.8× 20 0.4× 6 0.2× 58 384
Nicole-Ann Lim Singapore 9 74 0.6× 69 0.9× 37 0.6× 17 0.3× 7 0.2× 19 252
Elisa Zaragoza‐Macias United States 8 180 1.5× 21 0.3× 35 0.6× 95 1.9× 27 0.9× 14 387
Başak Çoruh United States 8 20 0.2× 45 0.6× 22 0.4× 31 0.6× 17 0.6× 33 226
Guilherme Schneider Brazil 8 25 0.2× 55 0.7× 49 0.8× 25 0.5× 7 0.2× 24 237
Maria Marlene de Souza Pires Brazil 10 59 0.5× 117 1.5× 26 0.4× 49 1.0× 5 0.2× 28 400
Michelle Grunauer Ecuador 9 27 0.2× 37 0.5× 78 1.3× 24 0.5× 9 0.3× 51 297
Meriç Yavuz Çolak Türkiye 9 25 0.2× 119 1.5× 38 0.6× 33 0.6× 10 0.3× 33 301

Countries citing papers authored by Sigrid Vorobjov

Since Specialization
Citations

This map shows the geographic impact of Sigrid Vorobjov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigrid Vorobjov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigrid Vorobjov more than expected).

Fields of papers citing papers by Sigrid Vorobjov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sigrid Vorobjov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigrid Vorobjov. The network helps show where Sigrid Vorobjov may publish in the future.

Co-authorship network of co-authors of Sigrid Vorobjov

This figure shows the co-authorship network connecting the top 25 collaborators of Sigrid Vorobjov. A scholar is included among the top collaborators of Sigrid Vorobjov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigrid Vorobjov. Sigrid Vorobjov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hleyhel, Mira, Julia Geller, Paul Naaber, et al.. (2024). Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Estonia, July to December 2022. Eurosurveillance. 29(30). 1 indexed citations
2.
Parm, Ülle, Hiie Soeorg, Jelena Štšepetova, et al.. (2023). Effect of early directed implementation of family-integrated care measures on colonisation withEnterobacteriaceaein preterm neonates in NICU. BMJ Paediatrics Open. 7(1). e001712–e001712. 1 indexed citations
4.
Reile, Rainer, et al.. (2021). Perceived Stress During the First Wave of COVID-19 Outbreak: Results From Nationwide Cross-Sectional Study in Estonia. Frontiers in Public Health. 9. 7 indexed citations
5.
Uusküla, Anneli, et al.. (2020). The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review. International Journal of Drug Policy. 81. 102757–102757. 27 indexed citations
6.
Raag, Mait, Sigrid Vorobjov, & Anneli Uusküla. (2019). Prevalence of injecting drug use in Estonia 2010–2015: a capture-recapture study. Harm Reduction Journal. 16(1). 19–19. 7 indexed citations
7.
Uusküla, Anneli, Mait Raag, Sigrid Vorobjov, & Don C. Des Jarlais. (2018). Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study. Harm Reduction Journal. 15(1). 10–10. 6 indexed citations
10.
Uusküla, Anneli, Mait Raag, Sigrid Vorobjov, et al.. (2015). Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. BMC Public Health. 15(1). 1255–1255. 29 indexed citations
12.
Vorobjov, Sigrid, et al.. (2014). Anterior knee pain following total knee replacement correlates with the OARSI score of the cartilage of the patella. Acta Orthopaedica. 85(4). 427–432. 13 indexed citations
13.
Karro, Helle, Mati Rahu, & Sigrid Vorobjov. (2014). Eesti Meditsiinilise Sünniregistri andmete kvaliteet. Ajakirjad. Journals by UT.
14.
Vorobjov, Sigrid, et al.. (2014). Social skills and their relationship to drug use among 15-16-year-old students in Estonia: An analysis based on the ESPAD data. Nordic Studies on Alcohol and Drugs. 31(4). 401–412. 10 indexed citations
15.
Jürisson, Mikk, Sigrid Vorobjov, Riina Kallikorm, Margus Lember, & Anneli Uusküla. (2014). The incidence of hip fractures in Estonia, 2005–2012. Osteoporosis International. 26(1). 77–84. 14 indexed citations
16.
Vorobjov, Sigrid, Don C. Des Jarlais, Katri Abel‐Ollo, et al.. (2012). Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. International Journal of Drug Policy. 24(2). 150–155. 15 indexed citations
17.
Vorobjov, Sigrid, Anneli Uusküla, Don C. Des Jarlais, et al.. (2011). Multiple routes of drug administration and HIV risk among injecting drug users. Journal of Substance Abuse Treatment. 42(4). 413–420. 9 indexed citations
18.
Vorobjov, Sigrid, Anneli Uusküla, Katri Abel‐Ollo, Ave Talu, & Don C. Des Jarlais. (2009). Should Pharmacists have a Role in Harm Reduction Services for IDUs? A Qualitative Study in Tallinn, Estonia. Journal of Urban Health. 86(6). 918–928. 11 indexed citations
19.
Vorobjov, Sigrid, Anneli Uusküla, Katri Abel‐Ollo, et al.. (2009). Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduction Journal. 6(1). 3–3. 23 indexed citations
20.
Vorobjov, Sigrid, Sirpa‐Liisa Hovi, Piret Veerus, et al.. (2005). Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757]. Maturitas. 52(3-4). 286–295. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026